ID   ILK_HUMAN               Reviewed;         452 AA.
AC   Q13418; B7Z1I0; B7Z418; D3DQU0; P57043; Q68DZ3;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 2.
DT   12-OCT-2022, entry version 227.
DE   RecName: Full=Integrin-linked protein kinase {ECO:0000303|PubMed:8538749};
DE            EC=2.7.11.1 {ECO:0000303|PubMed:8538749};
DE   AltName: Full=59 kDa serine/threonine-protein kinase {ECO:0000303|PubMed:8538749};
DE   AltName: Full=Beta-integrin-linked kinase {ECO:0000250|UniProtKB:P57044};
DE   AltName: Full=ILK-1 {ECO:0000303|PubMed:10871859};
DE   AltName: Full=ILK-2 {ECO:0000303|PubMed:10871859};
DE   AltName: Full=p59ILK {ECO:0000303|PubMed:8538749};
GN   Name=ILK {ECO:0000312|HGNC:HGNC:6040};
GN   Synonyms=ILK1 {ECO:0000303|PubMed:10871859}, ILK2
GN   {ECO:0000303|PubMed:10871859};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND AUTOPHOSPHORYLATION.
RC   TISSUE=Placenta;
RX   PubMed=8538749; DOI=10.1038/379091a0;
RA   Hannigan G.E., Leung-Hagesteijn C., Fitz-Gibbon L., Coppolino M.G.,
RA   Radeva G., Filmus J., Bell J.C., Dedhar S.;
RT   "Regulation of cell adhesion and anchorage-dependent growth by a new beta
RT   1-integrin-linked protein kinase.";
RL   Nature 379:91-96(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10871859; DOI=10.1038/sj.onc.1203640;
RA   Janji B., Melchior C., Vallar L., Kieffer N.;
RT   "Cloning of an isoform of integrin-linked kinase (ILK) that is upregulated
RT   in HT-144 melanoma cells following TGF-beta1 stimulation.";
RL   Oncogene 19:3069-3077(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Tadic B., Hannigan G.E.;
RT   "Integrin-linked kinase genomic sequence.";
RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Melchior C., Janji B., Kreis S., Kieffer N.;
RT   "Structural organisation of the gene encoding integrin-linked kinase 1.";
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Cerebellum, and Colon;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Endometrium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   FUNCTION, AND MUTAGENESIS OF GLU-359.
RX   PubMed=9736715; DOI=10.1073/pnas.95.19.11211;
RA   Delcommenne M., Tan C., Gray V., Rue L., Woodgett J.R., Dedhar S.;
RT   "Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase
RT   kinase 3 and protein kinase B/AKT by the integrin-linked kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:11211-11216(1998).
RN   [12]
RP   REVIEW.
RX   PubMed=10712922; DOI=10.1016/s0955-0674(99)00083-6;
RA   Dedhar S.;
RT   "Cell-substrate interactions and signaling through ILK.";
RL   Curr. Opin. Cell Biol. 12:250-256(2000).
RN   [13]
RP   INTERACTION WITH PARVB, AND SUBCELLULAR LOCATION.
RX   PubMed=11402068; DOI=10.1083/jcb.153.6.1251;
RA   Yamaji S., Suzuki A., Sugiyama Y., Koide Y., Yoshida M., Kanamori H.,
RA   Mohri H., Ohno S., Ishigatsubo Y.;
RT   "A novel integrin-linked kinase-binding protein, affixin, is involved in
RT   the early stage of cell-substrate interaction.";
RL   J. Cell Biol. 153:1251-1264(2001).
RN   [14]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH LIMS1 AND LIMS2.
RX   PubMed=12167643; DOI=10.1074/jbc.m205576200;
RA   Zhang Y., Chen K., Guo L., Wu C.;
RT   "Characterization of PINCH-2, a new focal adhesion protein that regulates
RT   the PINCH-1-ILK interaction, cell spreading, and migration.";
RL   J. Biol. Chem. 277:38328-38338(2002).
RN   [15]
RP   INTERACTION WITH PARVA AND PARVB.
RX   PubMed=15284246; DOI=10.1074/jbc.m401563200;
RA   Zhang Y., Chen K., Tu Y., Wu C.;
RT   "Distinct roles of two structurally closely related focal adhesion
RT   proteins, alpha-parvins and beta-parvins, in regulation of cell morphology
RT   and survival.";
RL   J. Biol. Chem. 279:41695-41705(2004).
RN   [16]
RP   INTERACTION WITH PARVA AND PXN.
RX   PubMed=15817463; DOI=10.1074/jbc.m500752200;
RA   LaLonde D.P., Brown M.C., Bouverat B.P., Turner C.E.;
RT   "Actopaxin interacts with TESK1 to regulate cell spreading on
RT   fibronectin.";
RL   J. Biol. Chem. 280:21680-21688(2005).
RN   [17]
RP   INTERACTION WITH EPHA1.
RX   PubMed=19118217; DOI=10.1242/jcs.036467;
RA   Yamazaki T., Masuda J., Omori T., Usui R., Akiyama H., Maru Y.;
RT   "EphA1 interacts with integrin-linked kinase and regulates cell morphology
RT   and motility.";
RL   J. Cell Sci. 122:243-255(2009).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-186, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [22]
RP   INTERACTION WITH LIMD2, AND ACTIVITY REGULATION.
RX   PubMed=24590809; DOI=10.1158/0008-5472.can-13-1275;
RA   Peng H., Talebzadeh-Farrooji M., Osborne M.J., Prokop J.W., McDonald P.C.,
RA   Karar J., Hou Z., He M., Kebebew E., Orntoft T., Herlyn M., Caton A.J.,
RA   Fredericks W., Malkowicz B., Paterno C.S., Carolin A.S., Speicher D.W.,
RA   Skordalakes E., Huang Q., Dedhar S., Borden K.L., Rauscher F.J. III;
RT   "LIMD2 is a small LIM-only protein overexpressed in metastatic lesions that
RT   regulates cell motility and tumor progression by directly binding to and
RT   activating the integrin-linked kinase.";
RL   Cancer Res. 74:1390-1403(2014).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [24]
RP   FUNCTION, AND INTERACTION WITH CCDC25.
RX   PubMed=32528174; DOI=10.1038/s41586-020-2394-6;
RA   Yang L., Liu Q., Zhang X., Liu X., Zhou B., Chen J., Huang D., Li J.,
RA   Li H., Chen F., Liu J., Xing Y., Chen X., Su S., Song E.;
RT   "DNA of neutrophil extracellular traps promotes cancer metastasis via
RT   CCDC25.";
RL   Nature 583:133-138(2020).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 1-174 IN COMPLEX WITH LIMS1,
RP   DOMAIN ANK REPEATS, AND MUTAGENESIS OF HIS-99.
RX   PubMed=19074270; DOI=10.1073/pnas.0811415106;
RA   Chiswell B.P., Zhang R., Murphy J.W., Boggon T.J., Calderwood D.A.;
RT   "The structural basis of integrin-linked kinase-PINCH interactions.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:20677-20682(2008).
RN   [26]
RP   STRUCTURE BY NMR OF 1-171 IN COMPLEX WITH LIMS1, AND DOMAIN ANK REPEATS.
RX   PubMed=19117955; DOI=10.1074/jbc.m805319200;
RA   Yang Y., Wang X., Hawkins C.A., Chen K., Vaynberg J., Mao X., Tu Y.,
RA   Zuo X., Wang J., Wang Y.-X., Wu C., Tjandra N., Qin J.;
RT   "Structural basis of focal adhesion localization of LIM-only adaptor PINCH
RT   by integrin-linked kinase.";
RL   J. Biol. Chem. 284:5836-5844(2009).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 183-452 IN COMPLEX WITH PARVA, AND
RP   INTERACTION WITH PARVA.
RX   PubMed=20005845; DOI=10.1016/j.molcel.2009.11.028;
RA   Fukuda K., Gupta S., Chen K., Wu C., Qin J.;
RT   "The pseudoactive site of ILK is essential for its binding to alpha-parvin
RT   and localization to focal adhesions.";
RL   Mol. Cell 36:819-830(2009).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 183-452 IN COMPLEX WITH PARVA, AND
RP   INTERACTION WITH PARVA.
RX   PubMed=20117114; DOI=10.1016/j.jmb.2010.01.048;
RA   Im Y.J., Kang G.B., Lee J.H., Park K.R., Song H.E., Kim E., Song W.K.,
RA   Park D., Eom S.H.;
RT   "Structural basis for asymmetric association of the betaPIX coiled coil and
RT   shank PDZ.";
RL   J. Mol. Biol. 397:457-466(2010).
RN   [29]
RP   VARIANT VAL-262.
RX   PubMed=17646580; DOI=10.1161/circulationaha.107.689984;
RA   Knoell R., Postel R., Wang J., Kraetzner R., Hennecke G., Vacaru A.M.,
RA   Vakeel P., Schubert C., Murthy K., Rana B.K., Kube D., Knoell G.,
RA   Schaefer K., Hayashi T., Holm T., Kimura A., Schork N., Toliat M.R.,
RA   Nuernberg P., Schultheiss H.P., Schaper W., Schaper J., Bos E.,
RA   Den Hertog J., van Eeden F.J., Peters P.J., Hasenfuss G., Chien K.R.,
RA   Bakkers J.;
RT   "Laminin-alpha4 and integrin-linked kinase mutations cause human
RT   cardiomyopathy via simultaneous defects in cardiomyocytes and endothelial
RT   cells.";
RL   Circulation 116:515-525(2007).
CC   -!- FUNCTION: Receptor-proximal protein kinase regulating integrin-mediated
CC       signal transduction (PubMed:8538749, PubMed:9736715). May act as a
CC       mediator of inside-out integrin signaling (PubMed:10712922). Focal
CC       adhesion protein part of the complex ILK-PINCH (PubMed:10712922). This
CC       complex is considered to be one of the convergence points of
CC       integrin- and growth factor-signaling pathway (PubMed:10712922). Could
CC       be implicated in mediating cell architecture, adhesion to integrin
CC       substrates and anchorage-dependent growth in epithelial cells
CC       (PubMed:10712922). Regulates cell motility by forming a complex with
CC       PARVB (PubMed:32528174). Phosphorylates beta-1 and beta-3 integrin
CC       subunit on serine and threonine residues, but also AKT1 and GSK3B
CC       (PubMed:8538749, PubMed:9736715). {ECO:0000269|PubMed:32528174,
CC       ECO:0000269|PubMed:8538749, ECO:0000269|PubMed:9736715,
CC       ECO:0000303|PubMed:10712922}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:8538749};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:8538749};
CC   -!- ACTIVITY REGULATION: Stimulated rapidly but transiently by both cell
CC       fibronectin interactions, as well as by insulin, in a PI3-K-dependent
CC       manner, likely via the binding of PtdIns(3,4,5)P3 with a PH-like domain
CC       of ILK. The protein kinase activity is stimulated by LIMD2
CC       (PubMed:24590809). {ECO:0000269|PubMed:24590809}.
CC   -!- SUBUNIT: Interacts with the cytoplasmic domain of ITGB1
CC       (PubMed:10712922). Could also interact with integrin ITGB2, ITGB3
CC       and/or ITGB5 (PubMed:10712922). Interacts (via ANK repeats) with LIMS1
CC       and LIMS2 (PubMed:12167643, PubMed:19074270, PubMed:19117955).
CC       Interacts with PARVA (via C-terminus) and PARVB; these compete for the
CC       same binding site (PubMed:11402068, PubMed:15284246, PubMed:15817463,
CC       PubMed:20005845, PubMed:20117114). Interacts probably also with TGFB1I1
CC       (By similarity). Interacts (via ANK repeats) with EPHA1 (via SAM
CC       domain); stimulated by EFNA1 but independent of the kinase activity of
CC       EPHA1 (PubMed:19118217). Interacts with FERMT2 (By similarity).
CC       Interacts with LIMD2; leading to activate the protein kinase activity
CC       (PubMed:24590809). Interacts with PXN/PAXILLIN (via LD motif 4)
CC       (PubMed:15817463). Interacts with CCDC25 (via cytoplasmic region);
CC       initiating the ILK-PARVB cascade to induce cytoskeleton rearrangement
CC       and directional migration of cells (PubMed:32528174).
CC       {ECO:0000250|UniProtKB:O55222, ECO:0000269|PubMed:11402068,
CC       ECO:0000269|PubMed:12167643, ECO:0000269|PubMed:15284246,
CC       ECO:0000269|PubMed:15817463, ECO:0000269|PubMed:19074270,
CC       ECO:0000269|PubMed:19117955, ECO:0000269|PubMed:19118217,
CC       ECO:0000269|PubMed:20005845, ECO:0000269|PubMed:20117114,
CC       ECO:0000269|PubMed:24590809, ECO:0000269|PubMed:32528174,
CC       ECO:0000303|PubMed:10712922}.
CC   -!- INTERACTION:
CC       Q13418; Q14790: CASP8; NbExp=2; IntAct=EBI-747644, EBI-78060;
CC       Q13418; P55211: CASP9; NbExp=2; IntAct=EBI-747644, EBI-516799;
CC       Q13418; Q9NWT6: HIF1AN; NbExp=2; IntAct=EBI-747644, EBI-745632;
CC       Q13418; P08238: HSP90AB1; NbExp=2; IntAct=EBI-747644, EBI-352572;
CC       Q13418; Q9H0C8: ILKAP; NbExp=3; IntAct=EBI-747644, EBI-2620298;
CC       Q13418; P48059: LIMS1; NbExp=14; IntAct=EBI-747644, EBI-306928;
CC       Q13418; P48059-3: LIMS1; NbExp=3; IntAct=EBI-747644, EBI-12864460;
CC       Q13418; Q9NVD7: PARVA; NbExp=23; IntAct=EBI-747644, EBI-747655;
CC       Q13418; Q9HBI0: PARVG; NbExp=12; IntAct=EBI-747644, EBI-3921217;
CC       Q13418; Q6R327: RICTOR; NbExp=8; IntAct=EBI-747644, EBI-1387196;
CC       Q13418; Q9BWU0: SLC4A1AP; NbExp=8; IntAct=EBI-747644, EBI-1999704;
CC       Q13418; Q9UMS6: SYNPO2; NbExp=6; IntAct=EBI-747644, EBI-3453434;
CC       Q13418; P14373: TRIM27; NbExp=4; IntAct=EBI-747644, EBI-719493;
CC   -!- SUBCELLULAR LOCATION: Cell junction, focal adhesion
CC       {ECO:0000269|PubMed:11402068, ECO:0000269|PubMed:12167643}. Cell
CC       membrane; Peripheral membrane protein; Cytoplasmic side
CC       {ECO:0000269|PubMed:11402068}. Cell projection, lamellipodium
CC       {ECO:0000250|UniProtKB:O55222}. Cytoplasm, myofibril, sarcomere
CC       {ECO:0000269|PubMed:11402068}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q13418-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13418-2; Sequence=VSP_054920;
CC       Name=3;
CC         IsoId=Q13418-3; Sequence=VSP_055925;
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart followed by skeletal
CC       muscle, pancreas and kidney. Weakly expressed in placenta, lung and
CC       liver.
CC   -!- DOMAIN: A PH-like domain is involved in phosphatidylinositol phosphate
CC       binding. {ECO:0000269|PubMed:19074270, ECO:0000269|PubMed:19117955}.
CC   -!- PTM: Autophosphorylated on serine residues.
CC       {ECO:0000269|PubMed:8538749}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB94832.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact. Was originally thought to be distinct gene (ILK2) (PubMed:10871859).; Evidence={ECO:0000305|PubMed:10871859};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U40282; AAC16892.1; -; mRNA.
DR   EMBL; AJ277481; CAB94832.1; ALT_SEQ; mRNA.
DR   EMBL; AF244139; AAF74449.1; -; Genomic_DNA.
DR   EMBL; AJ404847; CAB99253.1; -; Genomic_DNA.
DR   EMBL; AK293474; BAH11516.1; -; mRNA.
DR   EMBL; AK296628; BAH12404.1; -; mRNA.
DR   EMBL; CR407673; CAG28601.1; -; mRNA.
DR   EMBL; CR749220; CAH18077.1; -; mRNA.
DR   EMBL; AC091564; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471064; EAW68688.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68689.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68690.1; -; Genomic_DNA.
DR   EMBL; BC001554; AAH01554.1; -; mRNA.
DR   CCDS; CCDS60712.1; -. [Q13418-2]
DR   CCDS; CCDS60713.1; -. [Q13418-3]
DR   CCDS; CCDS7768.1; -. [Q13418-1]
DR   PIR; S68455; S68455.
DR   RefSeq; NP_001014794.1; NM_001014794.2. [Q13418-1]
DR   RefSeq; NP_001014795.1; NM_001014795.2. [Q13418-1]
DR   RefSeq; NP_001265370.1; NM_001278441.1. [Q13418-2]
DR   RefSeq; NP_001265371.1; NM_001278442.1. [Q13418-3]
DR   RefSeq; NP_004508.1; NM_004517.3. [Q13418-1]
DR   RefSeq; XP_005252961.1; XM_005252904.4. [Q13418-1]
DR   RefSeq; XP_005252962.1; XM_005252905.2. [Q13418-3]
DR   RefSeq; XP_011518367.1; XM_011520065.1. [Q13418-1]
DR   PDB; 2KBX; NMR; -; A=1-171.
DR   PDB; 3F6Q; X-ray; 1.60 A; A=1-170.
DR   PDB; 3IXE; X-ray; 1.90 A; A=1-174.
DR   PDB; 3KMU; X-ray; 1.80 A; A=183-452.
DR   PDB; 3KMW; X-ray; 2.00 A; A=183-452.
DR   PDB; 3REP; X-ray; 1.80 A; A=183-452.
DR   PDB; 4HI8; X-ray; 1.20 A; A=1-174.
DR   PDB; 4HI9; X-ray; 1.20 A; A=1-174.
DR   PDB; 6MIB; X-ray; 1.80 A; A=182-452.
DR   PDBsum; 2KBX; -.
DR   PDBsum; 3F6Q; -.
DR   PDBsum; 3IXE; -.
DR   PDBsum; 3KMU; -.
DR   PDBsum; 3KMW; -.
DR   PDBsum; 3REP; -.
DR   PDBsum; 4HI8; -.
DR   PDBsum; 4HI9; -.
DR   PDBsum; 6MIB; -.
DR   AlphaFoldDB; Q13418; -.
DR   BMRB; Q13418; -.
DR   SMR; Q13418; -.
DR   BioGRID; 109824; 269.
DR   CORUM; Q13418; -.
DR   DIP; DIP-38657N; -.
DR   IntAct; Q13418; 211.
DR   MINT; Q13418; -.
DR   STRING; 9606.ENSP00000379975; -.
DR   BindingDB; Q13418; -.
DR   ChEMBL; CHEMBL5247; -.
DR   GuidetoPHARMACOLOGY; 2041; -.
DR   GlyGen; Q13418; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q13418; -.
DR   MetOSite; Q13418; -.
DR   PhosphoSitePlus; Q13418; -.
DR   SwissPalm; Q13418; -.
DR   BioMuta; ILK; -.
DR   DMDM; 9973397; -.
DR   OGP; Q13418; -.
DR   EPD; Q13418; -.
DR   jPOST; Q13418; -.
DR   MassIVE; Q13418; -.
DR   MaxQB; Q13418; -.
DR   PaxDb; Q13418; -.
DR   PeptideAtlas; Q13418; -.
DR   PRIDE; Q13418; -.
DR   ProteomicsDB; 59396; -. [Q13418-1]
DR   ProteomicsDB; 6331; -.
DR   ProteomicsDB; 6564; -.
DR   Antibodypedia; 23909; 832 antibodies from 43 providers.
DR   DNASU; 3611; -.
DR   Ensembl; ENST00000299421.9; ENSP00000299421.4; ENSG00000166333.14. [Q13418-1]
DR   Ensembl; ENST00000396751.6; ENSP00000379975.2; ENSG00000166333.14. [Q13418-1]
DR   Ensembl; ENST00000420936.6; ENSP00000403487.2; ENSG00000166333.14. [Q13418-1]
DR   Ensembl; ENST00000528995.5; ENSP00000435323.1; ENSG00000166333.14. [Q13418-2]
DR   Ensembl; ENST00000532063.5; ENSP00000434492.2; ENSG00000166333.14. [Q13418-3]
DR   GeneID; 3611; -.
DR   KEGG; hsa:3611; -.
DR   MANE-Select; ENST00000299421.9; ENSP00000299421.4; NM_004517.4; NP_004508.1.
DR   UCSC; uc010rap.3; human. [Q13418-1]
DR   CTD; 3611; -.
DR   DisGeNET; 3611; -.
DR   GeneCards; ILK; -.
DR   HGNC; HGNC:6040; ILK.
DR   HPA; ENSG00000166333; Low tissue specificity.
DR   MIM; 602366; gene.
DR   neXtProt; NX_Q13418; -.
DR   OpenTargets; ENSG00000166333; -.
DR   PharmGKB; PA29855; -.
DR   VEuPathDB; HostDB:ENSG00000166333; -.
DR   eggNOG; KOG0195; Eukaryota.
DR   GeneTree; ENSGT00940000155956; -.
DR   HOGENOM; CLU_000288_7_35_1; -.
DR   InParanoid; Q13418; -.
DR   OMA; NMADAKF; -.
DR   PhylomeDB; Q13418; -.
DR   TreeFam; TF315194; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   PathwayCommons; Q13418; -.
DR   Reactome; R-HSA-446343; Localization of the PINCH-ILK-PARVIN complex to focal adhesions.
DR   Reactome; R-HSA-446353; Cell-extracellular matrix interactions.
DR   SignaLink; Q13418; -.
DR   SIGNOR; Q13418; -.
DR   BioGRID-ORCS; 3611; 291 hits in 1128 CRISPR screens.
DR   ChiTaRS; ILK; human.
DR   EvolutionaryTrace; Q13418; -.
DR   GeneWiki; Integrin-linked_kinase; -.
DR   GenomeRNAi; 3611; -.
DR   Pharos; Q13418; Tchem.
DR   PRO; PR:Q13418; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q13418; protein.
DR   Bgee; ENSG00000166333; Expressed in body of uterus and 204 other tissues.
DR   ExpressionAtlas; Q13418; baseline and differential.
DR   Genevisible; Q13418; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005925; C:focal adhesion; IDA:ARUK-UCL.
DR   GO; GO:0030027; C:lamellipodium; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0030017; C:sarcomere; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl.
DR   GO; GO:0000902; P:cell morphogenesis; IMP:ARUK-UCL.
DR   GO; GO:0030030; P:cell projection organization; IEA:Ensembl.
DR   GO; GO:0007160; P:cell-matrix adhesion; IBA:GO_Central.
DR   GO; GO:0045197; P:establishment or maintenance of epithelial cell apical/basal polarity; IEA:Ensembl.
DR   GO; GO:0010761; P:fibroblast migration; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IDA:MGI.
DR   GO; GO:0022011; P:myelination in peripheral nervous system; IEA:Ensembl.
DR   GO; GO:2000178; P:negative regulation of neural precursor cell proliferation; IEA:Ensembl.
DR   GO; GO:0021675; P:nerve development; IEA:Ensembl.
DR   GO; GO:0061351; P:neural precursor cell proliferation; IEA:Ensembl.
DR   GO; GO:0003151; P:outflow tract morphogenesis; IEA:Ensembl.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IEA:Ensembl.
DR   GO; GO:0070527; P:platelet aggregation; HMP:UniProtKB.
DR   GO; GO:0030513; P:positive regulation of BMP signaling pathway; IEA:Ensembl.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IMP:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IEA:Ensembl.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IMP:UniProtKB.
DR   GO; GO:1901224; P:positive regulation of NIK/NF-kappaB signaling; IMP:CAFA.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0042327; P:positive regulation of phosphorylation; IMP:UniProtKB.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IMP:UniProtKB.
DR   GO; GO:0009967; P:positive regulation of signal transduction; IMP:UniProtKB.
DR   GO; GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IGI:ARUK-UCL.
DR   GO; GO:0043491; P:protein kinase B signaling; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0034446; P:substrate adhesion-dependent cell spreading; IMP:UniProtKB.
DR   GO; GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IMP:CAFA.
DR   CDD; cd14057; PK_ILK; 1.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR035692; PK_ILK.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   Pfam; PF12796; Ank_2; 2.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   SMART; SM00248; ANK; 3.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 3.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ANK repeat; ATP-binding;
KW   Cell junction; Cell membrane; Cell projection; Cytoplasm; Kinase; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..452
FT                   /note="Integrin-linked protein kinase"
FT                   /id="PRO_0000086020"
FT   REPEAT          2..30
FT                   /note="ANK 1"
FT   REPEAT          31..63
FT                   /note="ANK 2"
FT   REPEAT          64..96
FT                   /note="ANK 3"
FT   REPEAT          97..129
FT                   /note="ANK 4"
FT   REPEAT          130..174
FT                   /note="ANK 5"
FT   DOMAIN          193..446
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          33..139
FT                   /note="Interaction with LIMS1"
FT                   /evidence="ECO:0000269|PubMed:12167643"
FT   REGION          180..212
FT                   /note="PH-like; mediates interaction with TGFB1I1"
FT   BINDING         199..207
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         220
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:22223895,
FT                   ECO:0007744|PubMed:22814378"
FT   MOD_RES         186
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         426
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O55222"
FT   VAR_SEQ         1..134
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055925"
FT   VAR_SEQ         118..206
FT                   /note="DLVANGALVSICNKYGEMPVDKAKAPLRELLRERAEKMGQNLNRIPYKDTFW
FT                   KGTTRTRPRNGTLNKHSGIDFKQLNFLTKLNENHSGE -> SGQRRWARISTVFHTRTH
FT                   SGRGPPALGP (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_054920"
FT   VARIANT         262
FT                   /note="A -> V (found in a patient with severe dilated
FT                   cardiomyopathy; unknown pathological significance;
FT                   dbSNP:rs387907366)"
FT                   /evidence="ECO:0000269|PubMed:17646580"
FT                   /id="VAR_069753"
FT   MUTAGEN         99
FT                   /note="H->D: Alters interaction with LIMS1."
FT                   /evidence="ECO:0000269|PubMed:19074270"
FT   MUTAGEN         359
FT                   /note="E->K: Inactivation of ILK."
FT                   /evidence="ECO:0000269|PubMed:9736715"
FT   HELIX           4..10
FT                   /evidence="ECO:0007829|PDB:4HI8"
FT   HELIX           13..21
FT                   /evidence="ECO:0007829|PDB:4HI8"
FT   HELIX           37..43
FT                   /evidence="ECO:0007829|PDB:4HI8"
FT   HELIX           47..55
FT                   /evidence="ECO:0007829|PDB:4HI8"
FT   HELIX           70..76
FT                   /evidence="ECO:0007829|PDB:4HI8"
FT   HELIX           80..88
FT                   /evidence="ECO:0007829|PDB:4HI8"
FT   HELIX           92..94
FT                   /evidence="ECO:0007829|PDB:2KBX"
FT   HELIX           103..109
FT                   /evidence="ECO:0007829|PDB:4HI8"
FT   HELIX           113..121
FT                   /evidence="ECO:0007829|PDB:4HI8"
FT   STRAND          126..128
FT                   /evidence="ECO:0007829|PDB:4HI8"
FT   STRAND          131..133
FT                   /evidence="ECO:0007829|PDB:2KBX"
FT   HELIX           136..139
FT                   /evidence="ECO:0007829|PDB:4HI8"
FT   HELIX           142..154
FT                   /evidence="ECO:0007829|PDB:4HI8"
FT   TURN            167..169
FT                   /evidence="ECO:0007829|PDB:4HI9"
FT   HELIX           190..192
FT                   /evidence="ECO:0007829|PDB:3KMU"
FT   STRAND          194..202
FT                   /evidence="ECO:0007829|PDB:3KMU"
FT   STRAND          205..212
FT                   /evidence="ECO:0007829|PDB:3KMU"
FT   STRAND          215..222
FT                   /evidence="ECO:0007829|PDB:3KMU"
FT   HELIX           229..238
FT                   /evidence="ECO:0007829|PDB:3KMU"
FT   HELIX           239..242
FT                   /evidence="ECO:0007829|PDB:3KMU"
FT   STRAND          255..257
FT                   /evidence="ECO:0007829|PDB:3KMU"
FT   TURN            259..261
FT                   /evidence="ECO:0007829|PDB:3KMU"
FT   STRAND          262..264
FT                   /evidence="ECO:0007829|PDB:3KMU"
FT   STRAND          266..270
FT                   /evidence="ECO:0007829|PDB:3KMU"
FT   HELIX           277..282
FT                   /evidence="ECO:0007829|PDB:3KMU"
FT   HELIX           291..308
FT                   /evidence="ECO:0007829|PDB:3KMU"
FT   STRAND          311..313
FT                   /evidence="ECO:0007829|PDB:3KMU"
FT   STRAND          324..327
FT                   /evidence="ECO:0007829|PDB:3KMU"
FT   STRAND          333..336
FT                   /evidence="ECO:0007829|PDB:3KMU"
FT   HELIX           337..339
FT                   /evidence="ECO:0007829|PDB:3KMU"
FT   HELIX           353..355
FT                   /evidence="ECO:0007829|PDB:3KMU"
FT   HELIX           358..362
FT                   /evidence="ECO:0007829|PDB:3KMU"
FT   HELIX           365..367
FT                   /evidence="ECO:0007829|PDB:3KMU"
FT   HELIX           370..387
FT                   /evidence="ECO:0007829|PDB:3KMU"
FT   TURN            391..394
FT                   /evidence="ECO:0007829|PDB:3KMU"
FT   HELIX           397..406
FT                   /evidence="ECO:0007829|PDB:3KMU"
FT   HELIX           419..428
FT                   /evidence="ECO:0007829|PDB:3KMU"
FT   HELIX           433..435
FT                   /evidence="ECO:0007829|PDB:3KMU"
FT   HELIX           439..449
FT                   /evidence="ECO:0007829|PDB:3KMU"
SQ   SEQUENCE   452 AA;  51419 MW;  E37DC2AD5311A1C2 CRC64;
     MDDIFTQCRE GNAVAVRLWL DNTENDLNQG DDHGFSPLHW ACREGRSAVV EMLIMRGARI
     NVMNRGDDTP LHLAASHGHR DIVQKLLQYK ADINAVNEHG NVPLHYACFW GQDQVAEDLV
     ANGALVSICN KYGEMPVDKA KAPLRELLRE RAEKMGQNLN RIPYKDTFWK GTTRTRPRNG
     TLNKHSGIDF KQLNFLTKLN ENHSGELWKG RWQGNDIVVK VLKVRDWSTR KSRDFNEECP
     RLRIFSHPNV LPVLGACQSP PAPHPTLITH WMPYGSLYNV LHEGTNFVVD QSQAVKFALD
     MARGMAFLHT LEPLIPRHAL NSRSVMIDED MTARISMADV KFSFQCPGRM YAPAWVAPEA
     LQKKPEDTNR RSADMWSFAV LLWELVTREV PFADLSNMEI GMKVALEGLR PTIPPGISPH
     VCKLMKICMN EDPAKRPKFD MIVPILEKMQ DK
//
